Latest Pivotal News & Updates

See the latest news and media coverage for Pivotal. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Pivotal

Advanced air mobility aircraft manufacturer

pivotal.aero
Headquarters
Palo Alto, United States
Founded year
2016
Company type
Private company
Number of employees
150–200

Last updated

Latest news about Pivotal

In short: Pivotal advanced its eVTOL production and emergency response capabilities, achieving AS9100D certification and launching its first pilot program.

Company announcements

  • Pivotal

    Pivotal announces partnership with Hyde County and Code Blue Resources

    They launch a pilot program using Pivotal aircraft to reduce emergency response times in rural North Carolina.

  • Pivotal

    Pivotal highlights Helix aircraft upgrades

    Upgrades include stronger carbon fiber, improved motors, better battery, enhanced sensors, cooler canopy, and safer parachute. Achieved AS9100D certification.

  • Pivotal

    Pivotal achieves AS9100D certification

    This validates its Quality Management System after a multi-site audit. It marks a milestone for scaled Helix production.

  • Pivotal

    Pivotal appoints Philip Bethell VP of Manufacturing and Supply Chain

    Bethell brings 26 years of experience from Lockheed Martin, Tesla, Faraday Future, and Seurat Technologies. He will scale Helix production for public safety, personal aviation, and defense.

Unlock all announcements with a

Media coverage

  • Yahoo Finance

    Anteris treats first US patients in DurAVR pivotal trial

    Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has enrolled and successfully treated the first...

  • Investing.com

    Oncolytics surges on FDA alignment for pivotal cancer trial

    NEW YORK - Oncolytics Biotech Inc. (NASDAQ:ONCY) announced alignment with the U.S. Food and Drug Administration on the design of a pivotal clinical study for...

  • AP News

    BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100

    BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP) caused by carbapenem-resistant ...

  • The National Law Review

    Corcept Presents Complete Data from Pivotal ROSELLA Trial in SGO Late-Breaker with Simultaneous...

    ...Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating...

Unlock all articles with a

Never miss news about Pivotal

Track Pivotal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.